Efficacy, Safety and Tolerability Study of SHAPE in IA, IB or IIA Cutaneous T-cell Lymphoma

Clinical trial NCT02213861 · UNKNOWN

Trial details

NCT number: NCT02213861
Sponsor: TetraLogic Pharmaceuticals
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Cutaneous T-Cell Lymphoma (CTCL)

Start date: 2014-11-01
Primary completion: 2016-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.